J3530 HCPCS code: Nasal vaccine inhalation
J3530 is the HCPCS Level II code for nasal vaccine inhalation. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1986-01-01 |
| Last action effective | 1997-01-01 |
What changed for J3530
- 1986-01-01: J3530 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3530?
J3530 is the HCPCS Level II code for nasal vaccine inhalation. Short descriptor: "Nasal vaccine inhalation".
Does Medicare cover J3530?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Related J35 codes
- J3520 — Edetate disodium, per 150 mg
- J3535 — Drug administered through a metered dose inhaler
- J3570 — Laetrile, amygdalin, vitamin b17
- J3590 — Unclassified biologics
- J3591 — Unclassified drug or biological used for esrd on dialysis
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3530
- Watch J3530 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3530
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.